$84.71
+0.360 (+0.427%)
At Close: Jun 03, 2026
Akero Therapeutics (AKRO) Up on Positive NASH Study Data
03:53pm, Thursday, 25'th Aug 2022 Zacks Investment Research
Akero Therapeutics (AKRO) announces positive data from third cohort of its mid-stage study evaluating efruxifermin (EFX) in NASH. Stock up.
What Bear Market? These 3 Stocks Have Been Rocketing Higher in 2022
02:15pm, Thursday, 25'th Aug 2022 The Motley Fool
These three healthcare stocks have defied the 2022 bear market.
bluebird (BLUE) Up 101% in the Past Three Months: Here's Why
04:42pm, Tuesday, 23'rd Aug 2022 Zacks Investment Research
bluebird bio (BLUE) has surged in the past three months owing to its pipeline development. The company's lead candidate recently received FDA approval as a potential treatment for beta-thalassemia.
These Are The Ten Best And Worst Performing Small-Cap Stocks In July 2022
08:08pm, Monday, 22'nd Aug 2022
The small-cap Russell 2000 gained over 10% in July, compared to a jump of 9.1% for the S&P 500.
Aeglea BioTherapeutics (AGLE) Seeks EU Nod for ARG1-D Treatment
04:28pm, Monday, 22'nd Aug 2022 Zacks Investment Research
Aeglea BioTherapeutics (AGLE) seeks a nod for its lead candidate, pegzilarginase, for treating ARG1-D in the European Union. Stock surges post announcement.
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
07:28am, Tuesday, 16'th Aug 2022 Benzinga
Gainers
Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.
Liberty TripAdvisor Holdings, Inc. (NASDAQ: LT
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
04:05pm, Monday, 15'th Aug 2022 Benzinga
Gainers
Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New E
After Golden Cross, Rhythm Pharmaceuticals, Inc. (RYTM)'s Technical Outlook is Bright
01:55pm, Friday, 12'th Aug 2022 Zacks Investment Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Why Goldman Sachs Raised Its Price Target On This Biotech Stock By Nearly 5X
03:33pm, Monday, 08'th Aug 2022 Benzinga
The initial phase II data in patients with hypothalamic obesity (HO) has transformed the opportunity for Rhythm Pharmaceuticals Inc’s (NASDAQ: RYTM) Imcivree, according to Goldman Sachs.
The Rhythm
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
02:10pm, Monday, 08'th Aug 2022 Benzinga
Upgrades
For iRobot Corp (NASDAQ:IRBT), JP Morgan upgraded the previous rating of Underweight to Neutral. In the second quarter, iRobot showed an EPS of $0.35, compared to $0.27 from the year-ago qua
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
02:43pm, Friday, 05'th Aug 2022 Benzinga
Upgrades
For 8x8 Inc (NYSE:EGHT), Craig-Hallum upgraded the previous rating of Hold to Buy. In the first quarter, 8x8 showed an EPS of $0.09, compared to $0.01 from the year-ago quarter. At the moment
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
09:54am, Thursday, 04'th Aug 2022 Benzinga
Gainers
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.
ECMOHO Limited (NASDAQ: MOHO) jumped 146.1% to settle at $0.4085 on a
Moderna, PayPal And Some Other Big Gainers From Wednesday
08:00am, Thursday, 04'th Aug 2022 Benzinga
U.S. stocks closed higher on Wednesday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving higher in the previous session.
Ping Identity Holding Corp. (NYSE:
What 7 Analyst Ratings Have To Say About Rhythm Pharmaceuticals
05:22pm, Wednesday, 03'rd Aug 2022 Benzinga
Over the past 3 months, 7 analysts have published their opinion on Rhythm Pharmaceuticals (NASDAQ:RYTM) stock. These analysts are typically employed by large Wall Street banks and tasked with understa
Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth Conference
12:00pm, Wednesday, 03'rd Aug 2022 GlobeNewswire Inc.
BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families l
Sign In
Buy RYTM